Report calls for stronger IP protection of drugs in Canada

07/14/2013 | PharmaTimes (U.K.)

A report by Kristina Lybecker of the Fraser Institute, a Canadian public think tank, states that the country's weak protection of intellectual property in the pharmaceutical sector could hamper Canada's ability to negotiate global trade agreements and boost economic growth. Stronger intellectual property laws would reduce litigation, lower trade barriers, strengthen research and development, create jobs in the pharmaceutical sector and encourage medical innovation, Lybecker said, adding that these benefits would compensate for the estimated increase in drug expenditures of about $352 million to $866 million a year.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Clara, CA
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA